GlaxoSmithKline PLC Director/PDMR Shareholding (7266Y)

TIDMGSK

RNS Number : 7266Y

GlaxoSmithKline PLC

17 January 2022

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Mr D Redfern 
===  ========================  ============================================== 
 b)   Position/status          Chief Strategy Officer 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 13 January 2022, on Ordinary 
                                 Shares held within an ISA 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.3853    26 
                                               ---------- 
===  ========================  ============================================== 
 d)   Aggregated information   N/A (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================== 
 e)   Date of the transaction  2022-01-14 
===  ========================  ============================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Ms V Whyte 
===  ========================  ============================================== 
 b)   Position/status          Company Secretary 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 13 January 2022, on Ordinary 
                                 Shares held within an ISA 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.3853    22 
                                               ---------- 
===  ========================  ============================================== 
 d)   Aggregated information   N/A (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================== 
 e)   Date of the transaction  2022-01-14 
===  ========================  ============================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDDLFFLFLBBBX

(END) Dow Jones Newswires

January 17, 2022 12:04 ET (17:04 GMT)